Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocarditis | 5 | 2011 | 55 | 0.650 |
Why?
|
| Graft Rejection | 6 | 2019 | 1110 | 0.420 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2019 | 283 | 0.380 |
Why?
|
| Cardiac Myosins | 2 | 2008 | 19 | 0.360 |
Why?
|
| Heart Transplantation | 5 | 2019 | 774 | 0.360 |
Why?
|
| Trypanosoma cruzi | 4 | 2011 | 8 | 0.290 |
Why?
|
| Autoimmune Diseases | 3 | 2008 | 252 | 0.280 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2008 | 139 | 0.280 |
Why?
|
| Graft Survival | 4 | 2019 | 935 | 0.260 |
Why?
|
| Renin-Angiotensin System | 1 | 2007 | 82 | 0.260 |
Why?
|
| Transplantation Tolerance | 3 | 2016 | 142 | 0.260 |
Why?
|
| Autoimmunity | 4 | 2011 | 175 | 0.250 |
Why?
|
| Transplantation Immunology | 2 | 2019 | 83 | 0.250 |
Why?
|
| Immune Tolerance | 3 | 2019 | 359 | 0.230 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2016 | 419 | 0.210 |
Why?
|
| Listeriosis | 3 | 2019 | 87 | 0.190 |
Why?
|
| Listeria monocytogenes | 3 | 2019 | 94 | 0.190 |
Why?
|
| Staphylococcus aureus | 3 | 2014 | 281 | 0.180 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 2448 | 0.180 |
Why?
|
| Interleukin-17 | 2 | 2014 | 107 | 0.170 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 1108 | 0.170 |
Why?
|
| Mice | 16 | 2019 | 12110 | 0.170 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 279 | 0.160 |
Why?
|
| Interleukin-6 | 2 | 2011 | 272 | 0.150 |
Why?
|
| Protozoan Proteins | 2 | 2010 | 74 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 3360 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2019 | 461 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 333 | 0.130 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2007 | 95 | 0.130 |
Why?
|
| Animals | 17 | 2019 | 28003 | 0.130 |
Why?
|
| Antigen-Presenting Cells | 1 | 2016 | 142 | 0.120 |
Why?
|
| Isoantibodies | 1 | 2016 | 122 | 0.120 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2014 | 25 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2014 | 103 | 0.110 |
Why?
|
| Dermatitis | 1 | 2013 | 35 | 0.100 |
Why?
|
| Antigens, Protozoan | 2 | 2011 | 21 | 0.100 |
Why?
|
| Immunization | 2 | 2011 | 163 | 0.100 |
Why?
|
| Allografts | 3 | 2019 | 197 | 0.100 |
Why?
|
| Chagas Cardiomyopathy | 2 | 2011 | 4 | 0.090 |
Why?
|
| Th1 Cells | 2 | 2011 | 168 | 0.090 |
Why?
|
| Adoptive Transfer | 3 | 2016 | 173 | 0.090 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 172 | 0.090 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2010 | 4 | 0.090 |
Why?
|
| Trypanosomiasis, African | 1 | 2010 | 6 | 0.090 |
Why?
|
| Parasitemia | 1 | 2010 | 6 | 0.090 |
Why?
|
| Skin Transplantation | 1 | 2011 | 192 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 119 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2011 | 185 | 0.080 |
Why?
|
| Chagas Disease | 1 | 2008 | 3 | 0.070 |
Why?
|
| Hypersensitivity, Delayed | 2 | 2007 | 25 | 0.070 |
Why?
|
| Peptides | 1 | 2012 | 656 | 0.070 |
Why?
|
| Luminescent Measurements | 1 | 2008 | 62 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2008 | 131 | 0.070 |
Why?
|
| Luciferases | 1 | 2008 | 129 | 0.070 |
Why?
|
| Heart | 1 | 2011 | 584 | 0.070 |
Why?
|
| Captopril | 1 | 2007 | 22 | 0.070 |
Why?
|
| Nitroimidazoles | 1 | 2007 | 8 | 0.070 |
Why?
|
| Losartan | 1 | 2007 | 30 | 0.070 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2007 | 46 | 0.070 |
Why?
|
| Receptors, Angiotensin | 1 | 2007 | 12 | 0.070 |
Why?
|
| Organ Transplantation | 1 | 2011 | 288 | 0.070 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2007 | 31 | 0.070 |
Why?
|
| Autoantibodies | 2 | 2007 | 275 | 0.070 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2007 | 40 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 1589 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2008 | 453 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1016 | 0.060 |
Why?
|
| Cells, Cultured | 1 | 2008 | 2902 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2016 | 786 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2007 | 989 | 0.050 |
Why?
|
| Th17 Cells | 2 | 2011 | 95 | 0.040 |
Why?
|
| Mice, Congenic | 1 | 2019 | 12 | 0.040 |
Why?
|
| Lymphocyte Transfusion | 1 | 2019 | 40 | 0.040 |
Why?
|
| H-2 Antigens | 1 | 2019 | 57 | 0.040 |
Why?
|
| Isoantigens | 1 | 2019 | 72 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2019 | 276 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 165 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 177 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2019 | 177 | 0.040 |
Why?
|
| Cytokines | 2 | 2011 | 843 | 0.030 |
Why?
|
| Myosins | 2 | 2007 | 94 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2019 | 531 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2015 | 298 | 0.030 |
Why?
|
| Inflammation | 2 | 2011 | 1025 | 0.030 |
Why?
|
| T-Lymphocytes | 2 | 2012 | 1277 | 0.030 |
Why?
|
| B7-H1 Antigen | 1 | 2016 | 286 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2016 | 1015 | 0.030 |
Why?
|
| Male | 4 | 2008 | 43925 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2012 | 109 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2013 | 828 | 0.020 |
Why?
|
| Epitopes | 1 | 2012 | 249 | 0.020 |
Why?
|
| Methylprednisolone | 1 | 2011 | 68 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 333 | 0.020 |
Why?
|
| CD40 Ligand | 1 | 2011 | 73 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 371 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 741 | 0.020 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2011 | 207 | 0.020 |
Why?
|
| Female | 4 | 2015 | 47893 | 0.020 |
Why?
|
| RNA Interference | 1 | 2010 | 384 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2019 | 2458 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 2074 | 0.020 |
Why?
|
| Photons | 1 | 2008 | 48 | 0.020 |
Why?
|
| Binding Sites | 1 | 2010 | 1130 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 3017 | 0.020 |
Why?
|
| Humans | 4 | 2011 | 92337 | 0.020 |
Why?
|
| Fibrosis | 1 | 2007 | 239 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2004 | 0.020 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2004 | 31 | 0.010 |
Why?
|
| Cross Reactions | 1 | 2004 | 110 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2004 | 126 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1720 | 0.010 |
Why?
|
| Rats | 1 | 2008 | 4067 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2007 | 8740 | 0.010 |
Why?
|